Covovax receives WHO approval for emergency use Covovax receives WHO approval for emergency use
SATURDAY, DECEMBER 18, 2021
The World Health Organisation on Friday approved emergency use listing of Covid vaccine Covovax, produced by the Serum Institute of India under licence from Novavax and part of the Covax facility portfolio.